Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.
about
The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interactA unique pattern of cortical connectivity characterizes patients with attention deficit disorders: a large electroencephalographic coherence study.Autism, oxytocin and interoceptionTrophoblast inclusions are significantly increased in the placentas of children in families at risk for autism.Is 'bench-to-bedside' realistic for autism? An integrative neuroscience approachElectroencephalographic and early communicative abnormalities in Brattleboro rats.Long-term consequences of chronic fluoxetine exposure on the expression of myelination-related genes in the rat hippocampusThe role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.Prevalence and impact of unhealthy weight in a national sample of US adolescents with autism and other learning and behavioral disabilities.Effects of risperidone on core symptoms of autistic disorder based on childhood autism rating scale: an open label study.Motor Stereotypies: A Pathophysiological Review.Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse.Autism spectrum disorder: neuropathology and animal models.Advances in nonhuman primate models of autism: Integrating neuroscience and behavior.Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders.Cornelia de Lange and Ehlers-Danlos: comorbidity of two rare syndromes.Behavioural and emotional disorders in childhood: A brief overview for paediatricians.Common Defects of Spine Dynamics and Circuit Function in Neurodevelopmental Disorders: A Systematic Review of Findings From in Vivo Optical Imaging of Mouse Models.
P2860
Q28388719-CE971D4D-5AB2-4C62-A2CF-A1B59B3B17B2Q36301295-1B187D4C-07D2-4E08-81D8-C87EDD5B62BFQ36501651-6500A4E6-CC93-4AAC-A04B-A2A275724033Q37126976-F5996B4B-C32F-4EF9-BE55-13065D255CD4Q37134043-4EEA75FB-958F-40FA-9914-D620A6ABD779Q37344122-276A5A0A-5DED-432A-ADE6-73C95CC2BBB8Q37347736-5E066BF7-033E-4472-8209-45A902C24F48Q37559828-44CCFCD1-6AF8-4AE5-8D13-9DF656F7CFD7Q37669743-3A56BD11-45F5-4439-8E9B-7F50D5F7AA00Q38348189-7A28E608-048F-4D66-AB08-E3CEE33D5F55Q38730981-FE063158-5364-456E-B1E2-56B28E708AC7Q39164229-9CECC332-5751-432C-BD49-AA37A46BA58FQ39353531-6CA4156C-AA2D-41F7-B0F5-BAB827B8F73CQ46326120-B1031414-2C4F-434E-BBF1-8A29AD3416CBQ47835820-F0EDA11B-2398-40AE-871F-8E9D38F5F2F5Q48064923-C328DC3F-5534-4E83-B909-43C651FEC49DQ49873437-283FD9B6-5457-435F-BC38-11E30A25F2D7Q55474439-A4668B59-1F5A-4082-AE1D-40CA9CF19452
P2860
Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pharmacologic treatments for t ...... disorders across the lifespan.
@ast
Pharmacologic treatments for t ...... disorders across the lifespan.
@en
type
label
Pharmacologic treatments for t ...... disorders across the lifespan.
@ast
Pharmacologic treatments for t ...... disorders across the lifespan.
@en
prefLabel
Pharmacologic treatments for t ...... disorders across the lifespan.
@ast
Pharmacologic treatments for t ...... disorders across the lifespan.
@en
P2860
P921
P1476
Pharmacologic treatments for t ...... disorders across the lifespan.
@en
P2093
Carolyn A Doyle
Christopher J McDougle
P2860
P304
P5008
P577
2012-09-01T00:00:00Z